This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Cancer Reconstruction of Head & Neck  • Neoplasms of Head & Neck  • Pediatric Otolaryngology  • Skull Base Procedures  • Alert me on articles by topic

David M. Powell, MD; Nirav Shah, MD; Alan Carr, DDS; Shiva Shanker, DDS, MDS, MS; Jerry R. Dwek, MD; David E. Schuller, MD; Gregory J. Wiet, MD

Arch Otolaryngol Head Neck Surg. 2002;128:29-34.

Objective  To examine outcomes after the maxillary removal and reinsertion (MRR) approach for the treatment of anterior cranial base tumors in pediatric patients.

Design  Eligible patients were identified by medical record review. Consenting patients were studied via rhinoscopy, fiberoptic endoscopy, standard facial photographs, and cephalometric radiographs.

Setting  A tertiary care otolaryngology clinic.

Patients  Inclusion criteria were age younger than 16 years at time of initial procedure and a follow-up period of at least 6 months. Nine patients were eligible, and 5 enrolled. All were male patients (mean age, 13.8 years; age range, 11-15 years) treated for juvenile nasopharyngeal angiofibroma.

Main Outcome Measures  History and examination were performed to evaluate occlusion, vision, facial growth, and tumor status. Cephalograms were used to calculate 3 standard cephalometric measurements: sella to A point, basion to A point, and condylion to A point. Cephalograms were examined for plate migration and bony resorption.

Results and Conclusions  No major long-term complications were identified in the patients after MRR. Cephalometric analysis revealed minor abnormalities in 2 children, but no plate migration or bony resorption was identified in the removed and reinserted maxillae. No abnormal development patterns were detected on physical examination or when cephalometric measurements were compared with age- and race-matched normative data. Although further study is warranted, MRR seems safe and effective for treatment of pediatric patients with anterior cranial base tumors.

From the Department of Otolaryngology (Drs Powell and Schuller) and The School of Dentistry (Drs Carr and Shanker), The Ohio State University, and the Departments of Radiology (Dr Dwek) and Otolaryngology (Dr Wiet), Columbus Children's Hospital, Columbus; and the Department of Otolaryngology, Temple University, Philadelphia, Pa (Dr Shah).

RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2002;128(1):95-96.
FULL TEXT